These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5023836)

  • 1. Protection against the cardiotoxic effect of isoproterenol HCl by restricted food intake in rats.
    Balazs T; Arena E; Barron CN
    Toxicol Appl Pharmacol; 1972 Feb; 21(2):237-43. PubMed ID: 5023836
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of resistance to the ischemic cardiopathic effect of isoproterenol.
    Balazs T; Otake S; Noble JF
    Toxicol Appl Pharmacol; 1972 Feb; 21(2):200-13. PubMed ID: 5023834
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity and resistance of the myocardium to the toxicity of isoproterenol in rats.
    Balazs T; Johnson G; Joseph X; Ehrreich S; Bloom S
    Adv Exp Med Biol; 1983; 161():563-77. PubMed ID: 6869082
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection against the cardiotoxic effect of isoproterenol-HCl by dietary polyunsaturated fatty acids and exercise.
    Crandall DL; Griffith DR; Beitz DC
    Toxicol Appl Pharmacol; 1982 Jan; 62(1):152-7. PubMed ID: 7064150
    [No Abstract]   [Full Text] [Related]  

  • 5. Absolute and relative myocardial ischemia by isoproterenol overdosage.
    Blasig IE; Zipper J; Muschick P; Modersohn D; Löwe H
    Biomed Biochim Acta; 1985; 44(11-12):1641-9. PubMed ID: 4091837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of isoprenaline pretreatment on the cardiotoxic effect of the same drug.
    Faltová E; Mráz M; Sedivý J
    Physiol Bohemoslov; 1983; 32(4):307-17. PubMed ID: 6622555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in the lethal effect of isoproterenol in chronic hypocalcemic state but not in acute hypocalcemic state produced by parathyroidectomy in rats.
    Fujii T; Kondo S
    Jpn J Pharmacol; 1981 Jun; 31(3):451-4. PubMed ID: 7311157
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of subacute starvation on cardiac response to isoproterenol in rats.
    Basile-Filho A; Campos AC; Esteves SC; Bordin S; Mantovani M
    Nutrition; 1991; 7(4):280-2. PubMed ID: 1802219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats.
    Chatelain P; Gremel M; Brotelle R
    Eur J Pharmacol; 1987 Nov; 144(1):83-90. PubMed ID: 3436363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of caloric restriction on cardiac reactivity and beta-adrenoceptor concentration.
    Crandall DL; Lai FM; Huggins FJ; Tanikella TK; Cervoni P
    Am J Physiol; 1983 Mar; 244(3):H444-8. PubMed ID: 6299121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyroid hormone replacement on beta-adrenergic responsiveness of food-deprived rats.
    Barney CC; Wuertz KE; Katovich MJ
    Am J Physiol; 1986 May; 250(5 Pt 2):R861-7. PubMed ID: 3010747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of coronary blood flow and hypoxia upon the cardiac responses to isoproterenol.
    Ahn C; Vasko JS
    Ann Thorac Surg; 1969 Jun; 7(6):500-8. PubMed ID: 5787205
    [No Abstract]   [Full Text] [Related]  

  • 13. Alprazolam decreases isoproterenol induced myocardial damage in the rat.
    Berkowitz K; Conahan S; Vogel WH
    Cardiovasc Res; 1988 Jun; 22(6):414-6. PubMed ID: 3224354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
    Hanton G; Longeart L; Lodola A
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):231-4. PubMed ID: 2047568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of heart rate to acute administration of isoproterenol in rats treated chronically with norethynodrel, ethinyl estradiol, and both combined.
    Fregly MJ; Thrasher TN
    Endocrinology; 1977 Jan; 100(1):148-54. PubMed ID: 830535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of isoproterenol cardiotoxicity by corticoids.
    Guideri G; Green M; Lehr D
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):197-212. PubMed ID: 694221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-adrenergic responsiveness of rats treated chronically with isoproterenol.
    Barney CC; Katovich MJ; Fregly MJ; Tyler PE
    Can J Physiol Pharmacol; 1980 Oct; 58(10):1170-3. PubMed ID: 6258764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats.
    Prince PS; Sathya B
    Eur J Pharmacol; 2010 Jun; 635(1-3):142-8. PubMed ID: 20206157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
    Falicov RE; Lipp H; Resnekov L; King S
    Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
    [No Abstract]   [Full Text] [Related]  

  • 20. -adrenergic blocking agents. 3-(3-Substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazoles.
    Wasson BK; Gibson WK; Stuart RS; Williams HW; Yates CH
    J Med Chem; 1972 Jun; 15(6):651-5. PubMed ID: 4402289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.